Effect of a Telephone Intervention Upon Self-Reported Medication Adherence and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs)

REFERENCES

• Ajzen, I. (1985). From intentions to actions: A theory of planned behavior. In J. Kuhl & J. Backman (Eds.), Action-control: From cognition to behavior (pp. 11–39). Heidelberg, Germany: Springer.
   Google Scholar
• Ajzen, I. (1991). The theory of planned behavior. Organic Behavior and Human Decisional Processes, 50, 179–211.
   Web of Science ®Google Scholar
• American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision ed.). Washington, DC: American Psychiatric Association.
   Google Scholar
• Beebe, L. H. (2001). Community nursing support for clients with schizophrenia, Archives of Psychiatric Nursing, 15(5), 214–222.
   PubMed Web of Science ®Google Scholar
• Beebe, L. H. (2002). Problems in community living identified by people with schizophrenia. Journal of Psychosocial Nursing and Mental Health Services, 40(2), 38–46.
   PubMedGoogle Scholar
• Beebe, L. H. (2005). Telephone Intervention Problem Solving (TIPS) for persons with schizophrenia. Directions in Psychiatric Nursing, 2(9), 103–111.
   Google Scholar
• Beebe, L. H., & Smith, K. (2010). Informed consent to research in persons with schizophrenia spectrum disorders. Nursing Ethics, 17(4), 425–434.
   PubMed Web of Science ®Google Scholar
• Beebe, L. H., Smith, K., Bennett, C., Bentley, K., Walters, A., Hancock, B., Farmer, S.Y., Earle, K., and White, S. (2010). Keeping in touch: Cell phone use in people with schizophrenia spectrum disorders. Journal of Psychosocial Nursing and Mental Health Services, 48(4), 32–37.
   PubMed Web of Science ®Google Scholar
• Beebe, L. H., Smith, K., Crye, C., Addonizio, C., Strunk, D. J., Martin, W., & Poche, J. (2008). Telenursing intervention increases psychiatric medication adherence in schizophrenia outpatients. Journal of the American Psychiatric Nurses’ Association, 14(3), 217–224.
   PubMedGoogle Scholar
• Beebe, L. H., & Tian, L. (2004). TIPS: Telephone Intervention –Problem Solving for persons with Schizophrenia. Issues in Mental Health Nursing, 25(3), 317–329.
   PubMedGoogle Scholar
• Carpenter, W. T., Jr., Gold, J. M., Lahti, A. C., Queem, C. A., Conley, R. R., Bartko, J. J., Kovnick, J., & Appelbaum, J. S. (2000). Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry, 57(6), 533–538.
   PubMed Web of Science ®Google Scholar
• Czobor, P., Van Dorn, R. A., Citrome, L., Kahn, R. S., Fleischhacker, W. W., & Volavka, J. (2015). Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies. European Neuropsychopharmacology, 25, 1158–1168.
   PubMed Web of Science ®Google Scholar
• DeRenzo, E. G., Conley, R. R., & Love, R. (1998). Assessment of capacity to give consent to research participation: State-of-the-art and beyond. Journal of Health Care Law and Policy, 1(1), 66–87.
   PubMedGoogle Scholar
• Falloon, I. R., Held, T., Roncone, R., Coverdale, J. H., & Laidlaw, T. M. (1998). Optimal treatment strategies to enhance recovery from schizophrenia. Australian and New Zealand Journal of Psychiatry, 32(1), 43–49.
   PubMed Web of Science ®Google Scholar
• Fialko, L., Garety, P. A., Kuipers, E., Dunn, G., Bebbington, P. E., Fowler, D., & Freeman D. (2008). A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophrenia Research, 100(1-3), 53–59.
   PubMed Web of Science ®Google Scholar
• Haddad, P. M., Brain, C., & Scott, J. (2014). Nonadherence with antipsychotic medication in schizophrenia: Challenges and management strategies. Patient Related Outcome Measures, 5, 43–62.
   PubMedGoogle Scholar
• Hegedus, A., & Kozel, B. (2014). Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review. International Journal of Mental Health Nursing, 23, 490–497.
   PubMed Web of Science ®Google Scholar
• Higashi, K., Medio, G., Littlewood, K. J., Diez, T., & Granstrom, O. (2013). Medication adherence in schizophrenia: Factors influencing adherence and consequences of nonadherence, a systematic literature review. Therapeutic and Advanced Psychopharmacology, 3(4), 200–218.
   PubMedGoogle Scholar
• Kay, S. R., Fiszbein, A., Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276.
   PubMed Web of Science ®Google Scholar
• Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002). Prevalence of and risk factors for medication non-adherence in patients with Schizophrenia: A comprehensive review of recent literature. Journal of Clinical Psychiatry, 63(10), 892–909.
   PubMed Web of Science ®Google Scholar
• Lam, D. H., Kuipers, L., & Leff, J. P. (1993). Family work with patients suffering from schizophrenia: The impact of training on psychiatric nurses’ attitude and knowledge. Journal of Advanced Nursing, 18(2), 233–237.
   PubMed Web of Science ®Google Scholar
• Leucht, S., Arbter, D., Engel, R. R., Kissling, W., & Davis, J.M. (2009). How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Molecular Psychiatry, 14, 429–447.
   PubMed Web of Science ®Google Scholar
• Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012). Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis. Lancet, 379, 2063–2071.
   PubMed Web of Science ®Google Scholar
• Liberman, R. P., Eckman, T. A., & Marder, S. R. (2001). Rehab rounds: Training in social problem solving among persons with schizophrenia. Psychiatric Services, 52(1), 31–33.
   PubMed Web of Science ®Google Scholar
• McGuckin, C., Prentice, G. R., McLaughlin, C. G., & Harkin, E. (2011). Prediction of self-monitoring compliance: Application of the theory of planned behaviour to chronic illness sufferers. Psychological Health and Medicine, 17(4), 478–487.
   PubMed Web of Science ®Google Scholar
• Ogedegbe, G., Mancuso, C. A., Allegrante, J. P., & Charlson, M. E. (2003). Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. Journal of Clinical Epidemiology, 56(6), 520–529.
   PubMed Web of Science ®Google Scholar
• Patrick, D. L., Burns, T., Morosini, P., Gagnon, D. D., Rothman, M., & Adriaenssen, I. (2009). Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia. Current Medical Research and Opinion, 25(2), 325–338.
   PubMed Web of Science ®Google Scholar
• Peitl, M. V., Peitl, V., Pavlovic, E., Proloscic, J., & Petric, D. (1996). Stigmatization of patients suffering from schizophrenia. Collegium Anthropologicum, 35(suppl 2), 141–145.
   Google Scholar
• Penn, D. L., & Mueser, K. T. (1996). Research update on the psychosocial treatment of schizophrenia. American Journal of Psychiatry, 153(5), 607–617.
   PubMed Web of Science ®Google Scholar
• Schooler, N. R., Keith, S. J., Severe, J. B., Matthews, S. M., Bellack, A. S., Glick, I. E.…, Woerner, M. G. (1997). Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment. Archives of General Psychiatry, 54(5), 453–463.
   PubMed Web of Science ®Google Scholar
• Suttajit, S., & Pilakanta, S. (2010). Impact of depression and social support on nonadherence to antipsychotic drugs in persons with schizophrenia in Thailand. Patient Preference and Adherence, 5(4), 363–368.
   Web of Science ®Google Scholar
• Tarrier, N., Lowson, K., & Barrowclough, C. (1991). Some aspects of family interventions in schizophrenia. II: Financial considerations. British Journal of Psychiatry, 159, 481–484.
   PubMed Web of Science ®Google Scholar
• Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Resarch, 42(3), 241–247.
   PubMed Web of Science ®Google Scholar
• Velligan, D. I., Lam, F., Ereshefsky, L., & Miller, A. L. (2003). Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications. Psychiatric Services, 54, 556–557.
   Web of Science ®Google Scholar
• Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J., Carpenter, D., Ross, R., & Dochtery, J. P. (2010). Strategies for assessment of adherence problems in patients with serious and persistent mental illness: Recommendations from the Expert Consensus Guidelines. Journal of Psychiatric Practice, 16(1), 34–45.
   PubMed Web of Science ®Google Scholar
• Yang, J., Ko, Y. H., Paik, J. W., Lee, M. S., Han, C., Joe, S. H., … Kim, S. H. (2012). Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia. Schizophrenia Research, 134(2-3), 226–231.
   PubMed Web of Science ®Google Scholar
• Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002). Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry, 159(10), 1653–1664.
   PubMed Web of Science ®Google Scholar